# Polygen Defi-Alpha: Genetic Polymorphisms Study in Children With Alpha-1 Antitrypsin Deficiency, Included in the DEFI-ALPHA Cohort

> **NCT01862211** · NA · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 296 (actual)

## Conditions studied

- Children With a Deficiency of Alpha-1 Antitrypsin

## Interventions

- **OTHER:** blood sampling

## Key facts

- **NCT ID:** NCT01862211
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2017-11
- **Final completion:** 2017-11
- **Target enrollment:** 296 (ACTUAL)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01862211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01862211, "Polygen Defi-Alpha: Genetic Polymorphisms Study in Children With Alpha-1 Antitrypsin Deficiency, Included in the DEFI-ALPHA Cohort". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01862211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
